AEGON USA Investment Management, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 45 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AEGON USA Investment Management, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2018$748,000
+6.7%
800,0000.0%0.22%
+11.5%
Q2 2018$701,0000.0%800,0000.0%0.20%
-2.0%
Q1 2018$701,000
-0.1%
800,0000.0%0.20%
+4.6%
Q4 2017$702,000
-83.6%
800,000
-80.0%
0.20%
-76.4%
Q3 2017$4,290,0000.0%4,000,0000.0%0.83%
-0.8%
Q2 2017$4,290,000
-0.1%
4,000,0000.0%0.84%
-11.7%
Q1 2017$4,295,000
-34.6%
4,000,000
-33.3%
0.95%
-31.5%
Q4 2016$6,570,000
-8.2%
6,000,0000.0%1.38%
-4.2%
Q3 2016$7,159,000
-4.8%
6,000,0000.0%1.44%
-18.8%
Q2 2016$7,519,000
-3.7%
6,000,0000.0%1.78%
-13.7%
Q1 2016$7,808,000
-16.7%
6,000,0000.0%2.06%
-12.6%
Q4 2015$9,368,000
+15.1%
6,000,0000.0%2.35%
+20.0%
Q3 2015$8,138,000
-4.7%
6,000,0000.0%1.96%
+2964.1%
Q2 2015$8,535,000
-3.9%
6,000,0000.0%0.06%0.0%
Q1 2015$8,880,000
-13.3%
6,000,000
-20.0%
0.06%
-19.0%
Q4 2014$10,247,000
+6.4%
7,500,0000.0%0.08%
-2.5%
Q3 2014$9,628,000
+0.4%
7,500,0000.0%0.08%
-6.9%
Q2 2014$9,586,000
+0.7%
7,500,0000.0%0.09%
-8.4%
Q1 2014$9,520,000
+19.5%
7,500,0000.0%0.10%
+10.5%
Q4 2013$7,964,000
+2.4%
7,500,0000.0%0.09%
-10.4%
Q3 2013$7,777,000
-1.0%
7,500,0000.0%0.10%
-14.3%
Q2 2013$7,856,0007,500,0000.11%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2016
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders